Benedi, A.; Beltrán-Visiedo, M.; Jiménez-Alduán, N.; Serrano-Del Valle, A.; Anel, A.; Naval, J.; Marzo, I.
Alisertib and Barasertib Induce Cell Cycle Arrest and Mitochondria-Related Cell Death in Multiple Myeloma with Enhanced Efficacy Through Sequential Combination with BH3-Mimetics and Panobinostat. Cancers 2025, 17, 2290.
https://doi.org/10.3390/cancers17142290
AMA Style
Benedi A, Beltrán-Visiedo M, Jiménez-Alduán N, Serrano-Del Valle A, Anel A, Naval J, Marzo I.
Alisertib and Barasertib Induce Cell Cycle Arrest and Mitochondria-Related Cell Death in Multiple Myeloma with Enhanced Efficacy Through Sequential Combination with BH3-Mimetics and Panobinostat. Cancers. 2025; 17(14):2290.
https://doi.org/10.3390/cancers17142290
Chicago/Turabian Style
Benedi, Andrea, Manuel Beltrán-Visiedo, Nelia Jiménez-Alduán, Alfonso Serrano-Del Valle, Alberto Anel, Javier Naval, and Isabel Marzo.
2025. "Alisertib and Barasertib Induce Cell Cycle Arrest and Mitochondria-Related Cell Death in Multiple Myeloma with Enhanced Efficacy Through Sequential Combination with BH3-Mimetics and Panobinostat" Cancers 17, no. 14: 2290.
https://doi.org/10.3390/cancers17142290
APA Style
Benedi, A., Beltrán-Visiedo, M., Jiménez-Alduán, N., Serrano-Del Valle, A., Anel, A., Naval, J., & Marzo, I.
(2025). Alisertib and Barasertib Induce Cell Cycle Arrest and Mitochondria-Related Cell Death in Multiple Myeloma with Enhanced Efficacy Through Sequential Combination with BH3-Mimetics and Panobinostat. Cancers, 17(14), 2290.
https://doi.org/10.3390/cancers17142290